The TGF-β signaling pathway contributes to impaired activation of cytotoxic T cells, enhanced activation of Tregs, and reduced activation of NK cells and DCs, thereby influencing the progression of HCC. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.